Things aren't good at Bayer, and that's just how the activist groups dead set on destroying the chemical company like it. At this week's shareholder meeting, 55% of Bayer shareholders refused to endorse the management. Chiefly, the shareholders were reacting to Bayer's acquisition of Monsanto, a deal that closed in June 2018. Since the Monsanto purchase, Bayer's stock value has dropped 38%. The reason, of course, is litigation against Roundup herbicide. With 13,400 lawsuits filed (at this point in time), and Bayer going 0 for 2 in their first two lawsuits, things are a little dicey. The activist groups are winning. In this episode I'll explain why they're winning, and what the future might hold. Hint: It'll be more lawsuits with a different target.
The Business of Agriculture Podcast